Phase I Study of ACTR707, an Autologous T cell Product,

Project: Research project

Project Details

Description

Phase I Study of ACTR707, an Autologous T cell Product, in Combination with Rituximab in Subjects with Relapsed or Refractory CD20+ B Cell Lymphoma
StatusActive
Effective start/end date8/1/178/30/21

Funding

  • UNUM THERAPEUTICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.